AnaptysBio, Inc. ANAB Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s stock issuance proceeds?
- AnaptysBio, Inc. (ANAB) reported stock issuance proceeds of $14.02M in Q1 2026.
- How has AnaptysBio, Inc.'s stock issuance proceeds changed year-over-year?
- AnaptysBio, Inc.'s stock issuance proceeds increased by 4734.8% year-over-year, from $290K to $14.02M.
- What is the long-term trend for AnaptysBio, Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s stock issuance proceeds has grown at a 53.7% compound annual growth rate (CAGR), from $2.55M to $14.26M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.